Present status and upcoming prospects of hedgehog pathway inhibitors in small cell lung cancer therapy
Tóm tắt
Lung cancer is an important etiology of malignant mortality worldwide with global statistics indicating over 1 million deaths annually. Although there have been advances in cytotoxic chemotherapy, the prognosis after treatment still remains poor. Remarkably, recent studies on the molecular level are creating the possibility to hamper lung cancer by inhibiting the hedgehog pathway. Currently, hedgehog pathway inhibitors include IWP-2, cyclopamine and aprotinin. However, Vismodegib is a new upcoming prospect which has shown positive results while undergoing clinical trials. If approved, it may lead to a novel class of anti-cancer therapy for patients seeking treatment for small cell lung cancer.
Tài liệu tham khảo
citation_journal_title=CA Cancer J Clin; citation_title=Global cancer statistics, 2002; citation_author=DM Parkin, F Bray, J Ferlay, P Pisani; citation_volume=55; citation_publication_date=2005; citation_pages=74-108; citation_doi=10.3322/canjclin.55.2.74; citation_id=CR1
citation_journal_title=Infectious Agents and Cancer; citation_title=Hedgehog pathway inhibitors – current status and future prospects; citation_author=A Sheikh, AA Alvi, HM Aslam; citation_volume=7; citation_publication_date=2012; citation_pages=29; citation_doi=10.1186/1750-9378-7-29; citation_id=CR2
citation_journal_title=Genes Dev; citation_title=Hedgehog: functions and mechanisms; citation_author=M Varjosalo, J Taipale; citation_volume=22; citation_issue=18; citation_publication_date=2008; citation_pages=2454-2472; citation_doi=10.1101/gad.1693608; citation_id=CR3
citation_journal_title=Nature; citation_title=Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis; citation_author=SP Thayer, MP Di Magliano, PW Heiser, CM Nielsen, DJ Roberts, GY Lauwers, YP Qi, S Gysin, C Fernandez-del Castillo, V Yajnik; citation_volume=425; citation_issue=6960; citation_publication_date=2003; citation_pages=851-856; citation_doi=10.1038/nature02009; citation_id=CR4
citation_journal_title=Acta Histochem; citation_title=Expression of hedgehog signaling molecules in lung cancer; citation_author=S Huang, L Yang, Y An, X Ma, C Zhang, G Xie, ZY Chen, J Xie, H Zhang; citation_volume=133; citation_issue=5; citation_publication_date=2011; citation_pages=564-569; citation_doi=10.1016/j.acthis.2010.06.003; citation_id=CR5
citation_journal_title=Mol Cancer; citation_title=Activation of the hedgehog pathway in advanced prostate cancer; citation_author=T Sheng, C Li, X Zhang, S Chi; citation_volume=3; citation_issue=1; citation_publication_date=2004; citation_pages=29; citation_doi=10.1186/1476-4598-3-29; citation_id=CR6
citation_journal_title=Cell Cycle; citation_title=Hedgehog signaling: progenitor phenotype in small-cell lung cancer; citation_author=DN Watkins, DM Berman, SB Baylin; citation_volume=2; citation_issue=3; citation_publication_date=2003; citation_pages=196-8; citation_doi=10.4161/cc.2.3.378; citation_id=CR7
citation_journal_title=Nature; citation_title=Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer; citation_author=DN Watkins, DM Berman, SG Burkholder, B Wang, PA Beachy, SB Baylin; citation_volume=422; citation_issue=6929; citation_publication_date=2003; citation_pages=313-7; citation_doi=10.1038/nature01493; citation_id=CR8
citation_journal_title=Nat Chem Biol; citation_title=Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer; citation_author=B Chen, ME Dodge, W Tang; citation_volume=5; citation_issue=2; citation_publication_date=2009; citation_pages=100-107; citation_doi=10.1038/nchembio.137; citation_id=CR9
citation_journal_title=Genes Dev; citation_title=Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened; citation_author=JK Chen, J Taipale, MK Cooper, PA Beachy; citation_volume=16; citation_issue=21; citation_publication_date=2002; citation_pages=2743-8; citation_doi=10.1101/gad.1025302; citation_id=CR10
citation_journal_title=Br J Cancer; citation_title=Anti-tumour activity of aprotinin; citation_author=AL Latner, E Longstaff, GA Turner; citation_volume=30; citation_issue=1; citation_publication_date=1974; citation_pages=60-7; citation_doi=10.1038/bjc.1974.113; citation_id=CR11
citation_journal_title=OncoTargets and Therapy; citation_title=Hedgehog pathway as a drug target: Smoothened inhibitors in development; citation_author=TL Lin, W Matsui; citation_volume=5; citation_publication_date=2012; citation_pages=547-558; citation_id=CR12
citation_journal_title=Proc Natl Acad Sci USA; citation_title=Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector; citation_author=J Kim, JJ Lee, J Kim, D Gardner, PA Beachy; citation_volume=107; citation_issue=30; citation_publication_date=2010; citation_pages=13432-7; citation_doi=10.1073/pnas.1006822107; citation_id=CR13
citation_journal_title=J Clin Oncol; citation_title=Clinical experience with Hedgehog pathway inhibitors; citation_author=JA Low, FJ de Sauvage; citation_volume=28; citation_issue=36; citation_publication_date=2010; citation_pages=5321-6; citation_doi=10.1200/JCO.2010.27.9943; citation_id=CR14
citation_journal_title=Clin Cancer Res; citation_title=Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors; citation_author=PM LoRusso, CM Rudin, JC Reddy; citation_volume=17; citation_issue=8; citation_publication_date=2011; citation_pages=2502-11; citation_doi=10.1158/1078-0432.CCR-10-2745; citation_id=CR15
citation_journal_title=Nat Rev Drug Discov; citation_title=Vismodegib; citation_author=A Dlugosz, S Agrawal, P Kirkpatrick; citation_volume=11; citation_issue=6; citation_publication_date=2012; citation_pages=437-438; citation_doi=10.1038/nrd3753; citation_id=CR16
citation_journal_title=Curr Opin Investig Drugs; citation_title=Vismodegib, a small-molecule inhibitor of the hedgehog pathway for the treatment of advanced cancers; citation_author=E De Smaele, E Ferretti, A Gulino; citation_volume=11; citation_issue=6; citation_publication_date=2010; citation_pages=707-18; citation_id=CR17
citation_journal_title=J Med Chem; citation_title=Identification, Characterization, and Implications of Species-Dependent Plasma Protein Binding for the Oral Hedgehog Pathway Inhibitor Vismodegib (GDC-0449); citation_author=AM Giannetti, H Wong, DJP Dijkgraaf; citation_volume=54; citation_issue=8; citation_publication_date=2011; citation_pages=2592-2601; citation_doi=10.1021/jm1008924; citation_id=CR18
citation_title=Erivedge [vismodegib; prescribing information]; citation_publication_date=2012; citation_id=CR19; citation_publisher=Genentech, Inc